Facial Skin Clinical and Microbial Profiling From Oral Probiotic Supplementation

NCT ID: NCT05597254

Last Updated: 2023-05-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

109 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-09-26

Study Completion Date

2022-12-09

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this double-blind randomized clinical trial is to investigate the effects on the skin from oral intake of probiotic supplements in healthy adult men and women. The main questions it aims to answer are: • Will probiotic supplementation result in beneficial changes to different skin parameters? • Will probiotic supplementation result in alterations in the skin microbiome? Participants will consume the study product daily for 8 weeks and come in for skin measurements at baseline and after 8 weeks.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Skin Manifestations

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Probiotic with niacin and berry extract

Group Type EXPERIMENTAL

Probiotic with niacin and berry extract

Intervention Type DIETARY_SUPPLEMENT

1 capsule daily of probiotic with niacin supplementation for 8 weeks

Probiotic without niacin and berry extract

Group Type ACTIVE_COMPARATOR

Probiotic without niacin and berry extract

Intervention Type DIETARY_SUPPLEMENT

1 capsule daily of probiotic without niacin supplementation for 8 weeks

Placebo

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DIETARY_SUPPLEMENT

1 capsule daily of placebo supplementation for 8 weeks

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Probiotic with niacin and berry extract

1 capsule daily of probiotic with niacin supplementation for 8 weeks

Intervention Type DIETARY_SUPPLEMENT

Probiotic without niacin and berry extract

1 capsule daily of probiotic without niacin supplementation for 8 weeks

Intervention Type DIETARY_SUPPLEMENT

Placebo

1 capsule daily of placebo supplementation for 8 weeks

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy volunteers
* Fully informed with the study specifications.
* Signed consent form prior to commencing the study.
* Motivated for participation in the study, and available over the full test period.
* Healthy skin on the face (i.e., absence of psoriasis, eczemas, erythema, oedema, scars, wounds, lesions, or any other type of inflammatory or autoimmune skin condition).
* Healthy gut (i.e., absence of irritable bowel diseases (IBD), irritable bowel syndrome (IBS), or any other type of inflammatory or autoimmune gut condition).
* No supplementation with probiotic, prebiotic or synbiotic products 2 weeks prior and/or during the whole study period.
* No supplementation with niacin (vitamin B3) 2 weeks prior and/or during the whole study period.
* No significant change in skin care routine (such as injectable cosmetics, skin tanning, etc.) throughout the whole study period.
* No significant change in the diet throughout the whole study period.

* Pregnant or lactating 3 months prior to study commencement or during the study.
* Women post menopause.
* Use of antibiotics at least 4 weeks prior and/or during the whole study period.
* Sun-tanned facial skin.
* Participating in another clinical study that could interfere with the present research.
* Presented health problems or specific medications that could adversely affect the study outcome.
* Presented any cutaneous hypersensitivity or allergy to cosmetic products.
* Major surgery on the face one year prior to study commencement.
* Applied any cleansing, topical or moisturizing product (including all make-up products) to the measurement area the morning of assessments at Oriflame Cosmetic AB.
* Exposure to artificial UV light and/or to the sun during the study.
* Special diets (vegan, low carbohydrate, weight loss diet, etc.).
* Significant change in weight one month before or during the study period.
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Oriflame Cosmetics AB

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Isabella Lee

Role: PRINCIPAL_INVESTIGATOR

Global Senior Nutritional Scientist

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Oriflame Cosmetics

Stockholm, , Sweden

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Sweden

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2022-00672-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Probiotics on Sleep Among Adults Study
NCT04767997 COMPLETED PHASE2
Two Supplemented Against Skin Reactivity
NCT01368224 COMPLETED PHASE3